Standard Biotools (LAB) Cash & Current Investments (2010 - 2026)
Standard Biotools (LAB) posted quarterly Cash & Current Investments of $455.2 million for Q1 2026, up 74.63% year-over-year from $260.7 million in Q1 2025, and up 142.66% quarter-over-quarter from $187.6 million in Q4 2025.
Standard Biotools (LAB) Cash & Current Investments (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Cash & Current Investments for 17 consecutive years, with $455.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Current Investments rose 74.63% year-over-year to $455.2 million; the TTM figure through Mar 2026 stood at $455.2 million (up 74.63% YoY), while the FY2025 annual figure was $187.6 million, down 36.41% from the prior year.
- Cash & Current Investments advanced to $455.2 million in Q1 2026 per LAB's latest filing, from $187.6 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $463.6 million in Q1 2024 and bottomed at $31.0 million in Q1 2022.
- Historically, Cash & Current Investments has averaged $235.1 million across 5 years, with a median of $194.9 million in 2025.
- Annual changes were most pronounced in 2022 — Cash & Current Investments jumped 20788.48% — and 2025, when it sank 46.98%.
- Standard Biotools' Cash & Current Investments stood at $166.8 million in 2022, then tumbled by 30.64% to $115.7 million in 2023, then soared by 154.96% to $295.0 million in 2024, then slumped by 36.41% to $187.6 million in 2025, then surged by 142.66% to $455.2 million in 2026.
- Business Quant data shows LAB's Cash & Current Investments at $455.2 million in Q1 2026, $187.6 million in Q4 2025, and $194.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.60 Bn | 194.00 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 127.14 Bn | 123.66 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.89 Bn | 109.67 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 73.11 Bn | 72.57 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 52.03 Bn | 47.78 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.31 Bn | 32.36 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Standard Biotools | 252.94 Mn | -223.78 Mn | 10.54 Mn | 476.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 476.72 Mn |
| Mar 31, 2026 | 455.18 Mn |
| Dec 31, 2025 | 187.58 Mn |
| Sep 30, 2025 | 194.90 Mn |
| Jun 30, 2025 | 237.09 Mn |
| Mar 31, 2025 | 260.65 Mn |
| Dec 31, 2024 | 294.96 Mn |
| Sep 30, 2024 | 367.62 Mn |
| Jun 30, 2024 | 396.00 Mn |
| Mar 31, 2024 | 463.57 Mn |
| Dec 31, 2023 | 115.69 Mn |
| Sep 30, 2023 | 129.65 Mn |
| Jun 30, 2023 | 143.10 Mn |
| Mar 31, 2023 | 155.33 Mn |
| Dec 31, 2022 | 166.80 Mn |
| Sep 30, 2022 | 186.18 Mn |
| Jun 30, 2022 | 212.23 Mn |
| Mar 31, 2022 | 31.00 Mn |
| Dec 31, 2021 | 29.47 Mn |
| Sep 30, 2021 | 30.33 Mn |